Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.88 EUR | 0.00% | +6.59% | -14.16% |
04-02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
03-29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 53.48M 57.41M 78.44M | Sales 2023 | 59.39M 63.76M 87.12M | Capitalization | 51.4M 55.18M 75.39M |
---|---|---|---|---|---|
Net income 2022 | 5M 5.37M 7.33M | Net income 2023 | 5M 5.37M 7.33M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 5.64M 6.06M 8.28M | Net Debt 2023 | 7.26M 7.79M 10.65M | EV / Sales 2023 | 0.99 x |
P/E ratio 2022 |
7.2
x | P/E ratio 2023 |
9.2
x | Employees | 79 |
Yield 2022 |
4.69% | Yield 2023 |
-
| Free-Float | 12.01% |
1 week | +6.59% | ||
Current month | -2.51% | ||
1 month | +4.86% | ||
3 months | -14.16% | ||
6 months | -14.54% | ||
Current year | -14.16% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 13-12-31 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 45 | 18-12-31 |
Lucio Fusaro
BRD | Director/Board Member | 68 | 21-12-31 |
Umberto di Maio
FOU | Founder | 51 | 14-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 3.88 | +2.65% | 25,500 |
24-04-30 | 3.78 | +5.00% | 5,250 |
24-04-29 | 3.6 | +1.12% | 3,250 |
24-04-26 | 3.56 | -1.11% | 7,250 |
24-04-25 | 3.6 | +2.27% | 7,250 |
Real-time Borsa Italiana, May 02, 2024 at 11:44 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.16% | 45.87M | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- SHE Stock